Enhanced Expression of CD44 Variants in Human Atheroma and Abdominal Aortic Aneurysm
Authors:
- 1 November 2004
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (5) , 1571-1581
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (HL-34636, HL-67249)
- Donald W. Reynolds Foundation
This publication has 63 references indexed in Scilit:
- Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular CellsCirculation, 2002
- Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and MacrophagesJournal of Experimental Medicine, 2002
- Ligation of CD40 on Vascular Smooth Muscle Cells Mediates Loss of Interstitial Collagen via Matrix Metalloproteinase ActivityAnnals of the New York Academy of Sciences, 2001
- Myoepithelial-Specific CD44 Shedding Is Mediated by a Putative Chymotrypsin-like SheddaseBiochemical and Biophysical Research Communications, 2000
- Decreased Elastin Deposition and High Proliferation of Fibroblasts from Costello Syndrome Are Related to Functional Deficiency in the 67-kD Elastin-Binding ProteinThe American Journal of Human Genetics, 2000
- Characterization of apoptotic macrophages in atheromatous tissue of humans and heritable hyperlipidemic rabbitsAtherosclerosis, 1999
- Regulation of CD44 Gene Expression by the Proinflammatory Cytokine Interleukin-1β in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1998
- CD44 Isoforms, Including the CD44 V3 Variant, Are Expressed on Endothelium, Suggesting a Role for CD44 in the Immobilization of Growth Factors and the Regulation of the Local Immune ResponseBiochemical and Biophysical Research Communications, 1998
- Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.Journal of Clinical Investigation, 1996
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994